Dane Andreeff - Aug 24, 2022 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Dane Andreeff
Stock symbol
HSDT
Transactions as of
Aug 24, 2022
Transactions value $
$63,501
Form type
4
Date filed
8/26/2022, 02:38 PM
Previous filing
May 25, 2022
Next filing
Sep 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSDT Common Stock Purchase $8.78K +13.5K +15.61% $0.65 100K Aug 24, 2022 See footnote F1
transaction HSDT Common Stock Purchase $1.87K +2.88K +15.01% $0.65 22.1K Aug 24, 2022 See footnote F2
transaction HSDT Common Stock Purchase $5.24K +8.06K +14.99% $0.65 61.8K Aug 24, 2022 See footnote F3
transaction HSDT Common Stock Purchase $489 +752 +16.23% $0.65 5.39K Aug 24, 2022 See footnote F4
transaction HSDT Common Stock Purchase $25.3K +40.1K +40.09% $0.63 140K Aug 25, 2022 See footnote F1
transaction HSDT Common Stock Purchase $5.39K +8.55K +38.72% $0.63 30.6K Aug 25, 2022 See footnote F2
transaction HSDT Common Stock Purchase $15.1K +23.9K +38.71% $0.63 85.8K Aug 25, 2022 See footnote F3
transaction HSDT Common Stock Purchase $1.41K +2.23K +41.42% $0.63 7.62K Aug 25, 2022 See footnote F4
holding HSDT Common Stock 1.51K Aug 24, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F2 The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3 The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.